Press Releases

Displays all press releases

RFK Jr.’s panel weakens guidance

Health and Human Services Secretary Robert F. Kennedy Jr.’s handpicked vaccine committee voted on Friday to do away with the long-standing, universal recommendation that all babies receive a hepatitis B shot at birth, issuing weaker guidance for certain infants. The group, called the Advisory Committee on Immunization Practices, or ACIP, recommended that parents use individual […]

RFK Jr.’s panel weakens guidance Read More »

CEO who used ChatGPT to talk to business icons: ‘Advice was so good’

Joanna Stober, Midi Health CEO and co-founder, has never had an opportunity to run her business plans past legendary venture capital investor John Doerr, chairman at Kleiner Perkins. But that didn’t stop her from tapping Doerr, in an AI version, for advice on growing her startup, a virtual clinic offering midlife health care for women.

CEO who used ChatGPT to talk to business icons: ‘Advice was so good’ Read More »

A biotech stock for investors scared to invest in the risky industry

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart

A biotech stock for investors scared to invest in the risky industry Read More »

Eli Lilly to build $6 billion Alabama manufacturing plant

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend

Eli Lilly to build $6 billion Alabama manufacturing plant Read More »

FDA approves Merck drug for decimated cattle herds to stop screwworm

Cattle detained in the pens of the Chihuahua Regional Livestock Union , at the Jeronimo-Santa Teresa border crossing in Ciudad Juarez, Mexico on November 27, 2024, after the United States stopped imports of Mexican cattle due to the presence of screwworm. Anadolu | Anadolu | Getty Images U.S. cattle ranchers will soon have a new

FDA approves Merck drug for decimated cattle herds to stop screwworm Read More »

Zealand Pharma unveils 2030 plan as weight loss competition heats up

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand

Zealand Pharma unveils 2030 plan as weight loss competition heats up Read More »

Eli Lilly’s weight loss drug retatrutide clears first late-stage study

The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025. Mike Blake | Reuters Eli Lilly on Thursday said its next-generation obesity drug delivered what appears to be the highest weight loss yet in a late-stage trial while reducing knee arthritis pain, clearing the first of several upcoming

Eli Lilly’s weight loss drug retatrutide clears first late-stage study Read More »

Food brands chase fibermaxxing trend with new high-fiber products

Workers are suspended on a Pepsi sign on a building outside of Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, U.S., February 9, 2024. Brian Snyder | Reuters One of this year’s top food trends is facing some tough competition. Protein captivated consumers and food companies in 2025, but fiber is increasingly stealing the

Food brands chase fibermaxxing trend with new high-fiber products Read More »

Scroll to Top